Pharmacology

An International Call To Action To Alleviate Drug Shortages

Society is in a tough spot. Drug companies are culturally vilified and routinely sued when things go bad- all in return for only a few years of profitability before anyone can make the new drugs they develop- the FDA is constantly under pressure to expedi ...

Article - News Staff - Jun 18 2012 - 1:00pm

Hyperparathyroidism Treatments To Decline Due To Fewer Product Launches And Increased Generic Erosion

GBI Research, a business intelligence provider, has released its latest research, 'Bone Metabolism Therapeutics Market to 2018- Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, He ...

Article - Anna Ohlden - Jun 19 2012 - 4:00pm

The Secret History Of Pain Killers

Looking at the latest statistics, it’s hard to miss one compelling trend: The over-prescription of painkillers is slowly but surely eclipsing the problem of illegal drugs. There are, of course, the usual culprits in this disturbing trend- from HMOs and the ...

Article - Greg Critser - Jun 20 2012 - 12:42pm

Positive CHMP Opinion For Teduglutide For Patients With Short Bowel Syndrome

Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending the granting of a mar ...

Article - Anna Ohlden - Jun 23 2012 - 7:30am

Ferumoxytol Receives European Authorziation For Treatment Of Iron Deficiency Anemia In Chronic Kidney Disease

Takeda Pharmaceutical Company Limited and AMAG Pharmaceuticals, Inc. today announced the granting of marketing authorization by the European Commission (EC) for ferumoxytol, a new intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adul ...

Article - Anna Ohlden - Jun 24 2012 - 5:30am

Miracle Cure Of The Week: Daffodils May Fix Depression

Plant compounds from a South African daffodil may be used to treat depression, according to a University of Copenhagen study, where they tested those substance in a laboratory model of the blood-brain barrier. Substances from the South African plant specie ...

Article - News Staff - Jun 22 2012 - 3:30pm

Positive Opinion For HUMIRA® In Non-radiographic Axial Spondyloarthritis From EMA's CHMP

Abbott announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for HUMIRA (adalimumab) in adults with severe axial spondyloarthritis (axSpA) who have no X-ray evidence of structural damage. Upon fina ...

Article - Anna Ohlden - Jun 26 2012 - 1:32am

VELCADE Receives Positive EU Regulatory Recommendation For Subcutaneous Administration

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of subcutaneous (under the skin) administrati ...

Article - Anna Ohlden - Jun 27 2012 - 1:30am

Shire's VPRIV® Shows Significant Improvement In Gaucher-Related Bone Disease

 In a head-to-head trial between VPRIV and Cerezyme(R) (imiglucerase), only patients treated with VPRIV experienced statistically significant improvement in lumbar spine bone mineral density at 9 months   Shire plc today presented new data that show VPRIV ...

Article - Anna Ohlden - Jun 28 2012 - 4:00pm

Interferon-Free Phase II Combination Trial With TMC435 And Daclatasvir

 A phase II interferon-free combination study with TMC435 and daclatasvir will evaluate treatment-naive or previous null responder patients with HCV genotype 1a and 1b- The study will include approx. 180 patients and will evaluate a combination of TMC435 ...

Article - Anna Ohlden - Jun 30 2012 - 5:00am